Does Glycine Sleep Onset Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Glycine Sleep Onset Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - The impact of insomnia disorder extends beyond just broken sleep, notably increasing the risk of mental health issues, interfering with daytime function, and adding to overall health concerns. [Cao ZhiGang (2026); evidence level 1] - A recent study found that insomnia costs more than $100 billion annually, driven primarily by indirect costs such as reduced workplace productivity, higher healthcare costs, and increased accident risk (). [Cao ZhiGang (2026); evidence level 1] - As a result, this technique demonstrates efficacy in maintaining a lasting effect on cortical excitability and neural connectivity (). [Cao ZhiGang (2026); evidence level 1] - An estimated 16.2% of the global adult population, roughly 852 million people, meets the diagnostic criteria for insomnia disorder, with about 7.9%, or roughly 415 million, affected by severe cases of insomnia (). [Cao ZhiGang (2026); evidence level 1] - Sleep is a complex biological process whose evolutionary purpose has remained equivocal for quite some time.More recently, however, compelling evidence has emerged, leading to recognition of the numerous metabolic and physiological functions sleep contributes to and actively supports. [Conti Federica (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.